Biostem

Biostem

Created using Figma
Teknologi sel biokimia yang sangat canggih dikombinasikan dengan teknologi blockchain.

Biostem adalah teknologi terdepan yang bertujuan untuk merevolusi industri medis dan biotek modern dengan menyediakan platform terdesentralisasi yang dapat digunakan untuk kegiatan transaksional, tujuan pelacakan, pembuatan kontrak dan outsourcing, Pemantauan dan pencatatan data pasien, perampingan siklus peralatan medis & perawatan kesehatan , pembuatan kontrak dan manajemen uji klinis. Dengan melakukan itu, kami juga bertujuan memastikan bahwa produk-produk Biotech modern tersedia untuk semua orang - tidak hanya orang kaya - dengan harga lebih murah.
PRE SALE
1 Apr 2019
30 Mei 2019
100% lengkap
Mengumpulkan dana - tanpa data
past
Detail Token
Distribusi Token
ICO Crowdfunding 30%
Founder Team 15%
Angel Funding 45%
Publisher 10%
Mata Uang yang Diterima
ETH
Detail Perusahaan
Negara Terdaftar
Malaysia
detil tambahan
Kategori
Peron, teknologi

Tentang Biostem

MYK was established as a biotechnology manufacturer and Biotech Research Laboratory aiming to contribute to the world health and medical industry through globalizing biotechnology. Its main business areas are: health and medical industry, finance and industrial investment, and sophisticated technologies such as blockchain and Biotechnology. MYK regards technology as the core and quality as its life, and wholeheartedly builds the company into a world-class branded enterprise. Comprised of a world-class medical team and cutting-edge biotechnology equipment, MYK provides a global scaled advanced medical technology and research service platform. It provides world-class screening, diagnosis, treatment and rehabilitation services for oncological diseases; has built patient-centered, unique health management system; provide community-based prevention, diagnosis, treatment, rehabilitation, and health services, while also providing medical services. In addition, anti-aging services are supplemented to create a brand-new living experience; in response to the needs of an aging population and the improvement of the quality of life of residents, the company has created the “MYK Cell Bank” as an important carrier for healthy living and provides high-end international medical care. Health management, health care services and other age-based health care services should provide strength for the common people to achieve physical and mental health and a better life.

Biostem is a project by MYK aiming to revolutionize the traditional Medical and Biotechnology industry by providing a decentralized blockchain for storing patient, clinical and research record, and smart contracts like features for trustless outsourcing of Biotech contracts.

Our Mission

Biostem aims to contribute to the world health and medical industry by creating an ecosystem that would make the Patient’s Clinical Record and the Biotech Contract Outsourcing process, distributed through a decentralized blockchain, so that, anyone can have access to high end, state of the art medical diagnosis, treatment and Biotech products at ease.

Biostem

Biostem is state of the art ERC-20 Virtual Currency that allows peer to peer mode of payment and is deployed on decentralized ethereum blockchain based technology. The currency would be used for funding the research work, daily transactional activities happening within the Biostem health and financial ecosystem, for health care services and can also be used as a peer to peer exchange and store of value between users: securely, efficiently at reduced costs. Biostem will utilize ethereum blockchain technology to enhance its services to patients, hospitals, research centers and daily consumers, sellers, and merchants. This allows a level of transparency that was previously unrealized, while incentivizing users to adopt and use the platform. This will be done through the creation and use of Biostems.

Biostem Tim

Diverifikasi 0%

Perhatian. Ada risiko bahwa anggota yang tidak diverifikasi sebenarnya bukan anggota tim

Dr. Rubern
Chief Executive Officer
tidak diverifikasi
Dawson Roland
Chief Technology Officer
tidak diverifikasi
Kelson Beck
Chief Marketing Officer
tidak diverifikasi
Matthew Hudson
Chief Financial Officer
tidak diverifikasi
Catherine Harrison
Chief Operating Officer
tidak diverifikasi
Rina
Biotech Consultant
tidak diverifikasi
Allyson Brock
Human Resource Director
tidak diverifikasi
Jozie Ayaz Khan
Business Development Director
tidak diverifikasi
Brayden Parker
Biotech Research Consultant
tidak diverifikasi
Sanjay Uttam Kharade
Business Consultant - Asia
tidak diverifikasi

Biostem Berita terakhir

  • Karena mungkin ada perbedaan waktu dalam pembaruan informasi, informasi akurat tentang setiap proyek ICO harus diverifikasi melalui situs resminya atau saluran komunikasi lainnya.
  • Informasi ini bukan saran atau saran tentang berinvestasi dalam pendanaan ICO. Silakan teliti sendiri informasi yang relevan dan putuskan partisipasi ICO.
  • Jika Anda merasa ada masalah atau masalah yang harus diperbaiki pada konten ini, atau jika Anda ingin mengirimkan proyek ICO Anda sendiri untuk dicantumkan, Harap email kami.
Silahkan baca disclaimer dan risk warning. Tampilkan disclaimer dan risk warning.